stars 1 stars 2 stars 3

CHEM-X-INFINITY is an independent company which provides libraries of small organic molecules for pharmaceutical and agrochemical use. Once a new receptor has been identified, the screening of diverse or focused libraries is now the usual beginning of a research program. Our team has been involved in parallel synthesis for over ten years. It has developed robust robotic methods and informatic tracking tools to quickly produce libraries of high quality. Our libraries are designed using medicinal chemistry filters and molecular modeling predictive tools to select the best combination of reagents. We work on original scaffolds and the originality of their applications. The libraries are focused on important medicinal themes, including GPCRs, kinases, peptidomimetics and fragments. We also offer diverse libraries suitable for first intention screenings. In order to broaden the field of investigation, we add new compounds to our collection every month. Our products are sold on a semi-exclusive basis. We design the projects to 100% in order to be able to supply fast resynthesis and synthesis of analogs. We also provide exclusive custom libraries on request.

CHEM-X-INFINITY Questions

The CHEM-X-INFINITY annual revenue was $5.7 million in 2026.

3 people are employed at CHEM-X-INFINITY.

CHEM-X-INFINITY is based in Romainville, Ile de France.

The NAICS codes for CHEM-X-INFINITY are [325, 32].

The SIC codes for CHEM-X-INFINITY are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users